Search

Author/Creator Janssen, M

14. SAT0037 The effects of b cell directed therapy on disease relevant biomarkers in subjects at risk of rheumatoid arthritis. (15th June 2017)

Authors:
Gerlag, D; Safy, M; Maijer, K; Ramwadhdoebe, T; Tas, S; Vries, N de; Starmans-Kool, M; Tubergen, A van; Janssen, M; Eyre, S; Klareskog, L; Zwinderman, K; Tak, P-P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis. Issue 4 (2nd September 2004)

Authors:
van Roon, E N; Jansen, T L T A; van de Laar, M A F J; Janssen, M; Yska, J P; Keuper, R; Houtman, P M; Brouwers, J R B J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 64:Issue 4(2005)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. THU0464 A genome-wide association study of gout in people of european ancestry. (15th June 2017)

Authors:
Merriman, TR; Cadzow, M; Merriman, M; Phipps-Green, A; Topless, R; Abhishek, A; Andres, M; Bradbury, L; Buchanan, R; Cremin, K; Guzman, E de; Zoysa, J de; Doherty, M; Hill, C; Huizinga, T; Jansen, T; Janssen, M; Joosten, L; Kurreeman, F; Lester, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗